Le Lézard
Classified in: Health
Subject: FVT

Apotex Inc. to Present at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference


TORONTO, April 16, 2024 /PRNewswire/ - Canada's largest pharmaceutical company, Apotex Inc. ("Apotex"), announced today that Allan Oberman, President & CEO, will be presenting at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference on Wednesday, April 17th, 2024 at 11:30 am EST.

About Apotex
Apotex Inc. is a Canadian-based global health company that produces high-quality, affordable and complex medicines for patients around the world, with a strategic focus on becoming a Canadian Health Champion and an Americas Partner of Choice. Apotex has an integrated portfolio of generic, biosimilar and innovative branded pharmaceutical products for global markets. Apotex employs over 7,000 people worldwide in manufacturing, R&D, and commercial operations. Apotex medicines are accessible to patients in more than 75 countries globally. Apotex is comprised of multiple divisions and affiliates, including Apotex Inc., focused on generic and specialty innovative medicines in Canada and internationally, Apotex Corp., an affiliate of Apotex Inc. which markets and sells products in the United States, and Apobiologix, a division of Apotex Inc. focused on biosimilar medicines. For more information, visit www.apotex.com.

SOURCE Apotex Inc.


These press releases may also interest you

at 11:48
Second Opinion Expert Announces Strategic Relationship with Intra Care Home Health Providers
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has formed a strategic relationship with Intra Care Home Health Providers, Inc. and its affiliated home health and hospice companies. The strategic...

at 11:30
Resolutions at BioInvent's Annual General Meeting 2024
BioInvent International (STO:BINV)The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") resolved to elect Laura Lassouw-Polman as new Board member, to re-elect the Board members Natalie Berner, Kristoffer...

at 11:25
KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance
KCAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a leading provider of flow cytometry and bioanalytical services located in Melbourne, Australia....

at 11:15
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer
Johnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study...

at 11:13
The Sporting Life 10K Will Host 20,000 in Toronto on Mother's Day, May 12, in Support of Campfire Circle
Sporting Life, the iconic sports and style retailer, is hosting the 24th annual Sporting Life 10K, sending thousands of participants down Yonge Street, with net proceeds supporting Campfire Circle. Since 2000, the Sporting Life 10K has raised more...

at 11:00
PharmAla Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has...

More news about Health...


News published on and distributed by: